Novo and Lilly gain on signs weight-loss pills could expand the market

0
114
Early data from weight-loss pills are lifting shares in Novo Nordisk and Eli Lilly as investors bet that easier-to-take drugs could expand the ​market to millions more patients and help counter pricing pressure.

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here